This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Therapeutic Apheresis Market

Therapeutic Apheresis is the New Innovation in the Healthcare Industry. Get to Know the Key Insights

Therapeutic Apheresis Market by Product Type, Technique, End User & Region - Forecast 2022 - 2032

Therapeutic Apheresis Market Outlook (2022-2032)

[324 Pages Report] The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2577.9 Mn in 2022 and is expected to reach US$ 5313 Mn by 2032. The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases.

Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells and transfusing of the remaining blood back into the donor during the procedure or at the end of it. Therapeutic apheresis is a process of removing blood components from a patient with apheresis technology.

Report Attribute

Details

Therapeutic Apheresis Market Value (2022)

US$ 2577.9 Million

Therapeutic Apheresis Market Anticipated Value (2032)

US$ 5313 Million

Therapeutic Apheresis Projected Growth Rate (2022-2032)

6.8%

Therapeutic apheresis is used for removing defective cells. It is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.

Basically, there are three types of therapeutic apheresis procedures used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX) and cellular depletions. Therapeutic plasma exchange is the elimination of a huge volume of plasma from the patient and replacing the plasma with suitable fluids. TPE is commonly used for the treatment of autoimmune diseases or immune-mediated diseases or disorders.

TPE removes paraproteins, monoclonal antibiotics, antigen-antibody, and autoimmune antibody complexes. Therapeutic apheresis particularly removes the significant proportion of one or more components causing diseases.

Customize this Report

Let us know your requirement to get
100% FREE customization

What Is Driving The Global Therapeutic Apheresis Market?

  • Growing need for several blood components, increasing prevalence of accidents globally, and additional government initiatives toward blood donation are a few primary drivers accelerating the therapeutic apheresis market.
  • The growing dominance of various therapeutic procedures such as fluid replacement therapy, red cell exchange, dendritic cells cancer therapy, car T cells therapy, and extracorporeal therapy are broadly stirring the growth rate of the global market.
  • Escalating trauma and injury cases, growing cases of chronic diseases, rising need for blood components and more awareness pertaining to blood safety, favorable reimbursement policies, and growing number of complicated surgical procedures are all responsible for the lucrative growth of the market.
  • Constantly increasing geriatric population coupled with increasing healthcare expenditure and growing use of therapeutic apheresis in treating cancer is likely to boost the growth of global therapeutic apheresis market.

Restraining Factors Hampering The Market Growth

  • Therapeutic apheresis procedures, apheresis devices, and installing the apheresis devices are an expensive affair and therefore the high cost associated with these procedures is anticipated to obstruct the growth of the therapeutic apheresis market.
  • Lack of awareness coupled with dearth of qualified specialists and problems associated with apheresis method is likely to suppress the global market expansion.
  • Apheresis results in growing occurrence of several disorders and diseases such as growth of germ cell tumors from stem cells of the germ line and early embryo, Guillain-Barré syndrome, Paraproteinemia, Waldenstrom's macroglobulinemia, non-Hodgkin’s lymphoma, symptomatic myeloma, and many others are broadly hindering the growth of the market.
  • Rental model’s installation of apheresis devices, strict donor recruitment criteria, and decreased blood donations using apheresis as a result of lack of awareness are likely to restrict the market further over the forecast period.
Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

North America To Dominate The Therapeutic Apheresis Market

North America accounted for the largest share, i.e., 32.6% market share in the global therapeutic apheresis market. Factors like growing demand for plasma-derived medicines production and well-established healthcare infrastructure. This region has smooth accessibility to advanced blood collection technologies. It also has the presence of some of the significant apheresis companies in the region.

Additionally, reasons such as soaring initiatives by the government towards blood donation coupled with the rising need for blood components across the globe. Moreover, approval of the latest indications for apheresis treatment, such as acute disseminated encephalomyelitis, autoimmune haemolytic anaemia, and neonatal cardiac lupus, support the growth of the market in this region.

Europe Likely To Portray A Promising Market For Therapeutic Apheresis

Europe is accountable for 28.9% market share in the global therapeutic apheresis market, owing to the growing prevalence of blood disorders such as profuse bleeding and a decrease in platelet count.

This region witnessed increasing cases of chronic diseases such as autoimmune diseases and cancer, and also growing number of organ donors also is supporting the growth of the market in this region.

The escalation in the rate of occurrence of chronic diseases, growing necessity for plasma sources, additional activities considering blood safety and increasing number of complicated surgical procedures are also fuelling the Europe therapeutic apheresis market.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Start-Up Ecosystem In The Therapeutic Apheresis Market

In June 2022, BioCaptiva raised nearly $2.6 million in latest seed funding to additionally develop its BioCaptis instrument which is an apheresis-based cell-free DNA capture device for using liquid biopsy testing. The financial round was led by existing investor Archangels, joined Scottish Enterprise, Cancer Research Horizons, and novel investor Old College Capital.

Key Players Benchmarking The Therapeutic Apheresis Market

Some of the key players in the network security firewalls market are Asahi Kasei Medical Co., Haemonetics Corporation, Miltenyi Biotec, Cerus Corporation, Terumo BCT Inc., Fresenius Kabi USA, Terumo Bct, B. Braun Melsungen AG, Nikkiso Co. Ltd., Medica S.p.A., Baxter Healthcare Corporation, Kawasumi Laboratories Inc., and Therakos Incorporation.

Who Terumo Bct
When July 2022
Strategic Move Terumo Blood and Cell Technologies, a medical technology company, and and Eliaz Therapeutics Inc., a medical device company, announced an exclusive collaboration to assist with fighting sepsis-induced acute kidney injury and Acute kidney injury by aiming on removal of an upstream inflammatory protein known as Galectin-3 from blood plasma.
Who Fresenius Kabi
When July 2022
Strategic Move Fresenius Kabi introduced Thiotepa for Injection, USP, in the United Sates. Thiotepa is a generic equivalent of Tepadina®, is the latest addition to the company’s injectable oncology portfolio – the most comprehensive in the industry. This injection is available immediately in solo-dose vials. It has several indications, which includes patients’ treatment with adenocarcinoma of the ovary or breast.
Who Miltenyi Biotec
When July 2022
Strategic Move Miltenyi Biotec, a global provider of products and services for cellular therapy and biomedical research announced the Class III certification of all its CliniMACS® Reagents for clinical-scale cell separation under the new European Regulation EU 2017/745 on medical devices.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 6.8% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Product Type
  • Technique
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • Terumo Bct
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

Key Segments Of The Therapeutic Apheresis Market

By Procedure Types:

  • Therapeutic Plasma Exchange (TPE)
  • Red Blood Cell Exchange (RBCX)
  • Cellular Depletions

By Technology:

  • Centrifugation
  • Membrane filtration

By Application:

  • Hematology
  • Neurology
  • Nephrology
  • Rheumatology
  • Oncology
  • Others

By End User:

  • Hospitals
  • Blood banks
  • Specialty clinics

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The growth outlook for the therapeutic apheresis market is predicted to advance at a CAGR of 6.8% from 2022 to 2032.

The North American region is anticipated to lead the therapeutic apheresis market during the forecast period.

The therapeutic apheresis market is likely to hold a valuation of US$ 5313 million by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure Types

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Procedure Types, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure Types, 2022-2032

        5.3.1. Therapeutic Plasma Exchange (TPE)

        5.3.2. Red Blood Cell Exchange (RBCX)

        5.3.3. Cellular Depletions

    5.4. Y-o-Y Growth Trend Analysis By Procedure Types, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Procedure Types, 2022-2032

6. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        6.3.1. Centrifugation

        6.3.2. Membrane Filtration

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032

7. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        7.3.1. Hematology

        7.3.2. Neurology

        7.3.3. Rheumatology

        7.3.4. Oncology

        7.3.5. Others

    7.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Application, 2022-2032

8. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        8.3.1. Hospitals

        8.3.2. Blood Banks

        8.3.3. Specialty Clinics

    8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    8.5. Absolute $ Opportunity Analysis By End User, 2022-2032

9. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Procedure Types

        10.2.3. By Technology

        10.2.4. By Application

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Procedure Types

        10.3.3. By Technology

        10.3.4. By Application

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Procedure Types

        11.2.3. By Technology

        11.2.4. By Application

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Procedure Types

        11.3.3. By Technology

        11.3.4. By Application

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. U.K.

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Procedure Types

        12.2.3. By Technology

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Procedure Types

        12.3.3. By Technology

        12.3.4. By Application

        12.3.5. By End User

    12.4. Key Takeaways

13. Asia Pacific Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

            13.2.1.4. India

            13.2.1.5. Malaysia

            13.2.1.6. Singapore

            13.2.1.7. Australia

            13.2.1.8. New Zealand

            13.2.1.9. Rest of APAC

        13.2.2. By Procedure Types

        13.2.3. By Technology

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Procedure Types

        13.3.3. By Technology

        13.3.4. By Application

        13.3.5. By End User

    13.4. Key Takeaways

14. MEA Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Procedure Types

        14.2.3. By Technology

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Procedure Types

        14.3.3. By Technology

        14.3.4. By Application

        14.3.5. By End User

    14.4. Key Takeaways

15. Key Countries Therapeutic Apheresis Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Procedure Types

            15.1.2.2. By Technology

            15.1.2.3. By Application

            15.1.2.4. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Procedure Types

            15.2.2.2. By Technology

            15.2.2.3. By Application

            15.2.2.4. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Procedure Types

            15.3.2.2. By Technology

            15.3.2.3. By Application

            15.3.2.4. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Procedure Types

            15.4.2.2. By Technology

            15.4.2.3. By Application

            15.4.2.4. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Procedure Types

            15.5.2.2. By Technology

            15.5.2.3. By Application

            15.5.2.4. By End User

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Procedure Types

            15.6.2.2. By Technology

            15.6.2.3. By Application

            15.6.2.4. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Procedure Types

            15.7.2.2. By Technology

            15.7.2.3. By Application

            15.7.2.4. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Procedure Types

            15.8.2.2. By Technology

            15.8.2.3. By Application

            15.8.2.4. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Procedure Types

            15.9.2.2. By Technology

            15.9.2.3. By Application

            15.9.2.4. By End User

    15.10. China

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Procedure Types

            15.10.2.2. By Technology

            15.10.2.3. By Application

            15.10.2.4. By End User

    15.11. Japan

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Procedure Types

            15.11.2.2. By Technology

            15.11.2.3. By Application

            15.11.2.4. By End User

    15.12. South Korea

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Procedure Types

            15.12.2.2. By Technology

            15.12.2.3. By Application

            15.12.2.4. By End User

    15.13. Malaysia

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Procedure Types

            15.13.2.2. By Technology

            15.13.2.3. By Application

            15.13.2.4. By End User

    15.14. Singapore

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Procedure Types

            15.14.2.2. By Technology

            15.14.2.3. By Application

            15.14.2.4. By End User

    15.15. Australia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Procedure Types

            15.15.2.2. By Technology

            15.15.2.3. By Application

            15.15.2.4. By End User

    15.16. New Zealand

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Procedure Types

            15.16.2.2. By Technology

            15.16.2.3. By Application

            15.16.2.4. By End User

    15.17. GCC Countries

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Procedure Types

            15.17.2.2. By Technology

            15.17.2.3. By Application

            15.17.2.4. By End User

    15.18. South Africa

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Procedure Types

            15.18.2.2. By Technology

            15.18.2.3. By Application

            15.18.2.4. By End User

    15.19. Israel

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Procedure Types

            15.19.2.2. By Technology

            15.19.2.3. By Application

            15.19.2.4. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Procedure Types

        16.3.3. By Technology

        16.3.4. By Application

        16.3.5. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Miltenyi Biotec

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Fresenius Kabi USA

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Terumo Bct, Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Baxter Healthcare Corporation

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Medica S.p.A.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Haemonetics Corporation

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Asahi Kasei Medical Co., Ltd

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Kaneka Corporation

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Kawasumi Laboratories Inc

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Cerus Corporation

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 02: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032

Table 03: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 04: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 05: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 06: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 07: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032

Table 08: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 09: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 10: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 11: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032

Table 13: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 14: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 15: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032

Table 18: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 19: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 20: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 21: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032

Table 23: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 24: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 25: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 26: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 27: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032

Table 28: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 29: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 30: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032

Figure 02: Global Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032

Figure 03: Global Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032

Figure 04: Global Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032

Figure 05: Global Therapeutic Apheresis Market Value (US$ Mn) by Region, 2022-2032

Figure 06: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 07: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 08: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 09: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032

Figure 10: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032

Figure 11: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032

Figure 12: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 13: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 14: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 15: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 16: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 17: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 18: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 19: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 20: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 21: Global Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032

Figure 22: Global Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032

Figure 23: Global Therapeutic Apheresis Market Attractiveness by Application, 2022-2032

Figure 24: Global Therapeutic Apheresis Market Attractiveness by End User, 2022-2032

Figure 25: Global Therapeutic Apheresis Market Attractiveness by Region, 2022-2032

Figure 26: North America Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032

Figure 27: North America Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032

Figure 28: North America Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032

Figure 29: North America Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032

Figure 30: North America Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032

Figure 31: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 32: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 33: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 34: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032

Figure 35: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032

Figure 36: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032

Figure 37: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 38: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 39: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 40: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 41: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 42: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 43: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 44: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 45: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 46: North America Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032

Figure 47: North America Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032

Figure 48: North America Therapeutic Apheresis Market Attractiveness by Application, 2022-2032

Figure 49: North America Therapeutic Apheresis Market Attractiveness by End User, 2022-2032

Figure 50: North America Therapeutic Apheresis Market Attractiveness by Country, 2022-2032

Figure 51: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032

Figure 52: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032

Figure 53: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032

Figure 54: Latin America Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032

Figure 55: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032

Figure 56: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 57: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 58: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 59: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032

Figure 60: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032

Figure 61: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032

Figure 62: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 63: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 64: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 65: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 66: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 67: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 68: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 69: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 70: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 71: Latin America Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032

Figure 72: Latin America Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032

Figure 73: Latin America Therapeutic Apheresis Market Attractiveness by Application, 2022-2032

Figure 74: Latin America Therapeutic Apheresis Market Attractiveness by End User, 2022-2032

Figure 75: Latin America Therapeutic Apheresis Market Attractiveness by Country, 2022-2032

Figure 76: Europe Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032

Figure 77: Europe Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032

Figure 78: Europe Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032

Figure 79: Europe Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032

Figure 80: Europe Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032

Figure 81: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 82: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 83: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 84: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032

Figure 85: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032

Figure 86: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032

Figure 87: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 88: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 89: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 90: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 91: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 92: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 93: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 94: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 95: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 96: Europe Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032

Figure 97: Europe Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032

Figure 98: Europe Therapeutic Apheresis Market Attractiveness by Application, 2022-2032

Figure 99: Europe Therapeutic Apheresis Market Attractiveness by End User, 2022-2032

Figure 100: Europe Therapeutic Apheresis Market Attractiveness by Country, 2022-2032

Figure 101: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032

Figure 102: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032

Figure 103: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032

Figure 104: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032

Figure 105: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032

Figure 106: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 107: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 108: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 109: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032

Figure 110: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032

Figure 111: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032

Figure 112: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 113: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 114: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 115: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 116: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 117: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 118: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 119: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 120: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 121: Asia Pacific Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032

Figure 122: Asia Pacific Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032

Figure 123: Asia Pacific Therapeutic Apheresis Market Attractiveness by Application, 2022-2032

Figure 124: Asia Pacific Therapeutic Apheresis Market Attractiveness by End User, 2022-2032

Figure 125: Asia Pacific Therapeutic Apheresis Market Attractiveness by Country, 2022-2032

Figure 126: MEA Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032

Figure 127: MEA Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032

Figure 128: MEA Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032

Figure 129: MEA Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032

Figure 130: MEA Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032

Figure 131: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 132: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 133: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 134: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032

Figure 135: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032

Figure 136: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032

Figure 137: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 138: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 139: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 140: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 141: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 142: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 143: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 144: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 145: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 146: MEA Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032

Figure 147: MEA Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032

Figure 148: MEA Therapeutic Apheresis Market Attractiveness by Application, 2022-2032

Figure 149: MEA Therapeutic Apheresis Market Attractiveness by End User, 2022-2032

Figure 150: MEA Therapeutic Apheresis Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Therapeutic Respiratory Devices Market

Published : March 2022

Healthcare

Pain Therapeutic Solutions Market

Published : February 2016

Healthcare

Therapeutic Drug Monitoring Market

Published : March 2022

Google translate

Therapeutic Apheresis Market